NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free BLFS Stock Alerts $17.05 +0.19 (+1.13%) (As of 09:44 AM ET) Add Compare Share Share Today's Range$16.41▼$17.0550-Day Range$15.14▼$18.8052-Week Range$8.92▼$24.50Volume22,426 shsAverage Volume406,482 shsMarket Capitalization$772.37 millionP/E RatioN/ADividend YieldN/APrice Target$23.40 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get BioLife Solutions alerts: Email Address BioLife Solutions MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside38.8% Upside$23.40 Price TargetShort InterestBearish6.84% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.37Based on 15 Articles This WeekInsider TradingSelling Shares$562,145 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.60) to ($0.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.35 out of 5 starsMedical Sector489th out of 908 stocksElectromedical Equipment Industry8th out of 18 stocks 3.5 Analyst's Opinion Consensus RatingBioLife Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageBioLife Solutions has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.84% of the outstanding shares of BioLife Solutions have been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 8.2.Change versus previous monthShort interest in BioLife Solutions has recently decreased by 3.12%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BLFS. Previous Next 2.4 News and Social Media Coverage News SentimentBioLife Solutions has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for BioLife Solutions this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for BLFS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows2 people have added BioLife Solutions to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $562,145.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for BioLife Solutions are expected to grow in the coming year, from ($0.60) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is -11.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is -11.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About BioLife Solutions Stock (NASDAQ:BLFS)BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.Read More BLFS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BLFS Stock News HeadlinesApril 24, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells 956 Shares of StockApril 20, 2024 | insidertrades.comTodd Berard Sells 10,000 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockApril 26, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 4, 2024 | insidertrades.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 4,000 Shares of StockApril 25, 2024 | investing.comBiolife Solutions exec sells shares worth over $8,900April 25, 2024 | investing.comBiolife Solutions exec sells shares worth over $5,000April 24, 2024 | americanbankingnews.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Troy Wichterman Sells 956 Shares of StockApril 20, 2024 | investing.comBioLife Solutions divests Stirling freezer subsidiaryApril 26, 2024 | Prosper Trading Academy (Ad)These AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet.April 20, 2024 | msn.comBioLife Solutions divest stirling freezer business to reduce cash burnApril 19, 2024 | bizjournals.comBioLife Solutions lays off 47 workers after divesting cold storage businessApril 18, 2024 | finance.yahoo.comInsider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...April 18, 2024 | prnewswire.comBioLife Solutions Announces the Divestiture of its Stirling Freezer BusinessApril 17, 2024 | americanbankingnews.comBioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Up 5.6% in MarchApril 4, 2024 | markets.businessinsider.comBuy Rating on BioLife Solutions: Focused Growth and Market Leadership Post-DivestitureMarch 30, 2024 | msn.comPowell: ‘No reason’ to think economy is close to recessionMarch 29, 2024 | finance.yahoo.comInvestors in BioLife Solutions (NASDAQ:BLFS) have unfortunately lost 49% over the last three yearsMarch 27, 2024 | finance.yahoo.comCorporate Insiders Are Selling These 10 Small-Cap StocksMarch 14, 2024 | finance.yahoo.comDirector Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS)March 13, 2024 | finance.yahoo.comInsider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS)March 8, 2024 | finance.yahoo.comWhen Will BioLife Solutions, Inc. (NASDAQ:BLFS) Become Profitable?March 4, 2024 | finance.yahoo.comBioLife Solutions to Present at TD Cowen and Key Bank Investor ConferencesMarch 2, 2024 | finance.yahoo.comBioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call TranscriptMarch 1, 2024 | finanznachrichten.deBioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Chimerix (CMRX)March 1, 2024 | finance.yahoo.comQ4 2023 BioLife Solutions Inc Earnings CallFebruary 29, 2024 | benzinga.comRecap: BioLife Solns Q4 EarningsSee More Headlines Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today4/26/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:BLFS CUSIPN/A CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees409Year FoundedN/APrice Target and Rating Average Stock Price Target$23.40 High Stock Price Target$25.00 Low Stock Price Target$22.00 Potential Upside/Downside+38.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-66,430,000.00 Net Margins-46.37% Pretax Margin-46.25% Return on Equity-13.36% Return on Assets-10.83% Debt Debt-to-Equity Ratio0.06 Current Ratio2.86 Quick Ratio1.83 Sales & Book Value Annual Sales$143.27 million Price / Sales5.33 Cash FlowN/A Price / Cash FlowN/A Book Value$7.67 per share Price / Book2.20Miscellaneous Outstanding Shares45,300,000Free Float44,077,000Market Cap$763.76 million OptionableOptionable Beta1.67 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Roderick de Greef (Age 64)CEO & Chairman Comp: $1.63MMr. Troy Wichterman (Age 39)Chief Financial Officer Comp: $485.2kMs. Karen Foster (Age 64)Chief Quality & Operations Officer Comp: $395.2kDr. Aby J. Mathew Ph.D. (Age 52)Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer Comp: $448.2kMr. Michael P. Rice (Age 61)Consultant Comp: $1.3MMr. Todd Berard (Age 55)Chief Marketing Officer Comp: $286.49kMs. Sarah Aebersold J.D. (Age 47)Chief Human Resources Officer Mr. Garrie Richardson B.Sc. (Age 51)M.B.A., Chief Revenue Officer More ExecutivesKey CompetitorsNatus MedicalNASDAQ:NTUSZynexNASDAQ:ZYXIAxoGenNASDAQ:AXGNEdap TmsNASDAQ:EDAPSoleno TherapeuticsNASDAQ:SLNOView All CompetitorsInsiders & InstitutionsMesirow Financial Investment Management Inc.Sold 6,147 shares on 4/26/2024Ownership: 0.045%New York State Teachers Retirement SystemSold 600 shares on 4/25/2024Ownership: 0.147%Sarah AebersoldSold 410 sharesTotal: $6,765.00 ($16.50/share)Mesirow Financial Investment Management Inc.Sold 6,147 shares on 4/19/2024Ownership: 0.045%Aby J MathewSold 584 sharesTotal: $8,941.04 ($15.31/share)View All Insider TransactionsView All Institutional Transactions BLFS Stock Analysis - Frequently Asked Questions Should I buy or sell BioLife Solutions stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioLife Solutions in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BLFS shares. View BLFS analyst ratings or view top-rated stocks. What is BioLife Solutions' stock price target for 2024? 4 analysts have issued twelve-month target prices for BioLife Solutions' shares. Their BLFS share price targets range from $22.00 to $25.00. On average, they predict the company's stock price to reach $23.40 in the next twelve months. This suggests a possible upside of 38.8% from the stock's current price. View analysts price targets for BLFS or view top-rated stocks among Wall Street analysts. How have BLFS shares performed in 2024? BioLife Solutions' stock was trading at $16.25 at the beginning of 2024. Since then, BLFS shares have increased by 3.8% and is now trading at $16.86. View the best growth stocks for 2024 here. Are investors shorting BioLife Solutions? BioLife Solutions saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,200,000 shares, an increase of 5.6% from the March 15th total of 3,030,000 shares. Based on an average daily trading volume, of 412,500 shares, the short-interest ratio is presently 7.8 days. View BioLife Solutions' Short Interest. When is BioLife Solutions' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our BLFS earnings forecast. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) issued its quarterly earnings results on Thursday, February, 29th. The medical equipment provider reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider had revenue of $32.73 million for the quarter, compared to analyst estimates of $32.70 million. BioLife Solutions had a negative trailing twelve-month return on equity of 13.36% and a negative net margin of 46.37%. What guidance has BioLife Solutions issued on next quarter's earnings? BioLife Solutions issued an update on its FY 2024 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $95.5 million-$100.0 million, compared to the consensus revenue estimate of $121.4 million. What is Mike Rice's approval rating as BioLife Solutions' CEO? 14 employees have rated BioLife Solutions Chief Executive Officer Mike Rice on Glassdoor.com. Mike Rice has an approval rating of 100% among the company's employees. This puts Mike Rice in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 89.0% of employees surveyed would recommend working at BioLife Solutions to a friend. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioLife Solutions investors own include Micron Technology (MU), AbbVie (ABBV), Cara Therapeutics (CARA), Gilead Sciences (GILD), Pfizer (PFE), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Twilio (TWLO) and Verastem (VSTM). Who are BioLife Solutions' major shareholders? BioLife Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.29%), New York State Teachers Retirement System (0.15%), Penbrook Management LLC (0.09%), Mesirow Financial Investment Management Inc. (0.05%), Mesirow Financial Investment Management Inc. (0.05%) and Register Financial Advisors LLC (0.01%). Insiders that own company stock include Aby J Mathew, Aby J Mathew, Amy Duross, Andrew G Hinson, Andrew G Hinson, Casdin Partners Master Fund, L, Geraint Phillips, Greef Roderick De, Joseph C Schick, Karen A Foster, Karen A Foster, Marcus Schulz, Michael Rice, Of The University Of C Regents, Sarah Aebersold, Todd Berard and Troy Wichterman. View institutional ownership trends. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BLFS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.